Neoadjuvant Chemotherapy with Cyclophosphamide, Mitoxantrone, and 5-Fluorouracil in Locally Advanced Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|28|2|81-85

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.2, 2005-01, pp. : 81-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Chemotherapy with Sequential Methotrexate and 5-Fluorouracil Scheduling, Epirubicin and Cisplatin for Locally Advanced Bladder Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Neoadjuvant and Adjuvant Chemotherapy of Locally Advanced Stomach Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 116-121

Karger

Access to resources Recommend Favorite

Prospective Phase II Study of Neoadjuvant Therapy with Cisplatin, 5-Fluorouracil, and Bevacizumab for Locally Advanced Resectable Esophageal Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 427-431

Karger

Access to resources Recommend Favorite

IOERT as anticipated tumor bed boost during breast‐conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer—Results of a case series after 5‐year follow‐up

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 5, 2015-03 ,pp. : 1193-1201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blood Flow Indices by Doppler Ultrasonography Vary with Neoadjuvant Chemotherapy but Are Not Related to Plasma VEGF Levels in Locally Advanced Breast Cancer

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 185-189

Karger

Access to resources Recommend Favorite